Effects of carvedilol reduce conjunctivitis through changes in inflammation, NGF and VEGF levels in a rat model

Chen,Ying; Hong,Xianfei

doi:10.3892/etm.2016.3140

Effects of carvedilol reduce conjunctivitis through changes in inflammation, NGF and VEGF levels in a rat model

Authors:
- Ying Chen
- Xianfei Hong
View Affiliations

Affiliations: Department of Ophthalmology, Jinhua Traditional Chinese Medical Hospital, Jinhua, Zhejiang 321000, P.R. China
Published online on: March 10, 2016 https://doi.org/10.3892/etm.2016.3140
Pages: 1987-1992

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Carvedilol is a novel third generation β-blocker that acts as an antagonist of β and α adrenergic receptors, and is able to regulate various cell factors. In addition, it possesses antioxidant activity, is capable of reversing cardiac remodeling effects and has anti-arrhythmic effects. The present study aimed to investigate whether the effects of carvedilol were able to reduce conjunctivitis clinical scores. Initially, 24 Sprague Dawley (SD) rats were randomly divided into three equal groups as follows: Control group, model group and carvedilol group. The model and carvedilol group adult SD rats were injected with lipopolysaccharide (LPS) to induce conjunctivitis. In the carvedilol group, the eight SD rats with LPS‑induced conjunctivitis also received 50 mg/kg/day of carvedilol for 4 weeks. Next, the effects carvedilol were assessed utilizing a system of clinical sign scores, and an enzyme‑linked immunosorbent assay was used to determine the expression levels of interleukin‑1β (IL‑1β), IL‑6, IL‑8 and tumor necrosis factor-α (TNF-α). Finally, nuclear factor‑κB (NF‑κB), nerve growth factor (NGF) and vascular endothelial growth factor (VEGF) were analyzed by western blotting. Carvedilol was observed to significantly reduce clinical sign scores in a dose‑dependent manner (P<0.01), and reduce IL‑1β, IL‑6, IL‑8 and TNF‑α expression levels (P<0.01) in the LPS‑induced rat model of conjunctivitis. Carvedilol was also able to significantly reduce the protein expression levels of NF-κB, and induce the protein expression levels of NGF and VEGF in the LPS‑induced rat model of conjunctivitis (P<0.01). In conclusion, the effects of carvedilol may reduce conjunctivitis clinical scores through inflammation, NGF and VEGF in LPS-induced rat models.

View Figures

View References

1	Saha S, Koley M, Ghosh S, Giri M, Das A and Goenka R: Documentation of prescriptions and clinical outcomes in a homeopathic hospital setting in West Bengal, India. J Evid Based Complementary Altern Med. 20:180–185. 2015. View Article : Google Scholar : PubMed/NCBI
2	Schwartz B, Harrison LH, Motter JS, Motter RN, Hightower AW and Broome CV: Investigation of an outbreak of Moraxella conjunctivitis at a Navajo boarding school. Am J Ophthalmol. 107:341–347. 1989. View Article : Google Scholar : PubMed/NCBI
3	Chen Y, Zhang X, Yang L, Li M, Li B, Wang W and Sheng M: Decreased PPAR-γ expression in the conjunctiva and increased expression of TNF-α and IL-1β in the conjunctiva and tear fluid of dry eye mice. Mol Med Rep. 9:2015–2023. 2014.PubMed/NCBI
4	Barisani-Asenbauer T, Inic-Kanada A, Belij S, Marinkovic E, Stojicevic I, Montanaro J, Stein E, Bintner N and Stojanovic M: The ocular conjunctiva as a mucosal immunization route: A profile of the immune response to the model antigen tetanus toxoid. PLoS One. 8:e606822013. View Article : Google Scholar : PubMed/NCBI
5	Koulikovska M, van der Ploeg I, Herrmann B and Montan PG: Respiratory syncytial virus and chlamydia are not detectable by PCR in ongoing vernal keratoconjunctivitis. Ocul Immunol Inflamm. 9:253–257. 2001. View Article : Google Scholar : PubMed/NCBI
6	Grayston JT, Woolridge RL, Chen CW, Assaad FA, Maffei S, Yen CH and Yang CY: Bacterial conjunctivitis caused by a base eye ointment used as a placebo. Rep U S Nav Med Res Lab. 4:1–11. 1960.
7	Doughty MJ: Sodium cromoglycate ophthalmic solution as a Pharmacy Medicine for the management of mild-to-moderate, non-infectious inflammation of the conjunctiva in adults. Ophthalmic Physiol Opt. 16(Suppl 2): S33–S38. 1996. View Article : Google Scholar : PubMed/NCBI
8	Buckley P and Lowman DM: Chronic non-infective conjunctivitis in rabbits. Lab Anim. 13:69–73. 1979. View Article : Google Scholar : PubMed/NCBI
9	Nell B, Walde I, Billich A, Vit P and Meingassner JG: The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: Results from an exploratory study. Vet Ophthalmol. 8:39–46. 2005. View Article : Google Scholar : PubMed/NCBI
10	Ferreri AJ, Dolcetti R, Du MQ, Doglioni C, Resti AG, Politi LS, De Conciliis C, Radford J, Bertoni F, Zucca E, et al: Ocular adnexal MALT lymphoma: An intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol. 19:835–846. 2008. View Article : Google Scholar : PubMed/NCBI
11	Chen J, Huang C, Zhang B, Huang Q, Chen J and Xu L: The effects of carvedilol on cardiac structural remodeling: The role of endogenous nitric oxide in the activity of carvedilol. Mol Med Rep. 7:1155–1158. 2013.PubMed/NCBI
12	Ronsein GE, Guidi DB, Benassi JC, Filho DW and Pedrosa RC and Pedrosa RC: Cytoprotective effects of carvedilol against oxygen free radical generation in rat liver. Redox Rep. 10:131–137. 2005. View Article : Google Scholar : PubMed/NCBI
13	Merayo-Lloves J, Zhao TZ, Dutt JE and Foster CS: A new murine model of allergic conjunctivitis and effectiveness of nedocromil sodium. J Allergy Clin Immunol. 97:1129–1140. 1996. View Article : Google Scholar : PubMed/NCBI
14	Gong L, Sun X, Qu J, Wang L, Zhang M, Zhang H, Wang L, Gu Y, Elion-Mboussa A, Roy L and Zhu B: Loteprednol etabonate suspension 0.2% administered QID compared with olopatadine solution 0.1% administered BID in the treatment of seasonal allergic conjunctivitis: A multicenter, randomized, investigator-masked, parallel group study in Chinese patients. Clin Ther. 34:1259–1272. 2012. View Article : Google Scholar : PubMed/NCBI
15	Chansaenroj J, Vongpunsawad S, Puenpa J, Theamboonlers A, Vuthitanachot V, Chattakul P, Areechokchai D and Poovorawan Y: Epidemic outbreak of acute haemorrhagic conjunctivitis caused by coxsackievirus A24 in Thailand, 2014. Epidemiol Infect. 143:3087–3093. 2015. View Article : Google Scholar : PubMed/NCBI
16	Chang CJ, Yang HH, Chang CA and Tsai HY: Relationship between air pollution and outpatient visits for nonspecific conjunctivitis. Invest Ophthalmol Vis Sci. 53:429–433. 2012. View Article : Google Scholar : PubMed/NCBI
17	Yasin MN, Hussain S, Malik F, Hameed A, Sultan T, Qureshi F, Riaz H, Perveen G and Wajid A: Preparation and characterization of chloramphenicol niosomes and comparison with chloramphenicol eye drops (0.5%w/v) in experimental conjunctivitis in albino rabbits. Pak J Pharm Sci. 25:117–121. 2012.PubMed/NCBI
18	Tanaka J, Tanaka H, Mizuki N, Nomura E, Ito N, Nomura N, Yamane M, Hida T, Goshima Y, Hatano H, et al: Semaphorin 3A controls allergic and inflammatory responses in experimental allergic conjunctivitis. Int J Ophthalmol. 8:1–10. 2015.PubMed/NCBI
19	Enríquez-de-Salamanca A, Calder V, Gao J, Galatowicz G, García-Vázquez C, Fernández I, Stern ME, Diebold Y and Calonge M: Cytokine responses by conjunctival epithelial cells: An in vitro model of ocular inflammation. Cytokine. 44:160–167. 2008. View Article : Google Scholar : PubMed/NCBI
20	Leonardi A, Curnow SJ, Zhan H and Calder VL: Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. Clin Exp Allergy. 36:777–784. 2006. View Article : Google Scholar : PubMed/NCBI
21	de Araújo Júnior RF, Souza TO, de Medeiros CA, de Souza LB, Freitas ML, de Lucena HF, do Socorro Costa Feitosa Alves M and de Araújo AA: Carvedilol decrease IL-1β and TNF-α, inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and up-regulates OPG in a rat model of periodontitis. PLoS One. 8:e663912013. View Article : Google Scholar : PubMed/NCBI
22	Arab HH and El-Sawalhi MM: Carvedilol alleviates adjuvant-induced arthritis and subcutaneous air pouch edema: Modulation of oxidative stress and inflammatory mediators. Toxicol Appl Pharmacol. 268:241–248. 2013. View Article : Google Scholar : PubMed/NCBI
23	Levi-Schaffer F, Micera A, Zamir E, Mechoulam H, Puxeddu I, Piliponsky AM, Aloe L and Pe'er J: Nerve growth factor and eosinophils in inflamed juvenile conjunctival nevus. Invest Ophthalmol Vis Sci. 43:1850–1856. 2002.PubMed/NCBI
24	Lambiase A, Bonini S, Micera A, Rama P, Bonini S and Aloe L: Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases. Invest Ophthalmol Vis Sci. 39:1272–1275. 1998.PubMed/NCBI
25	Kritas SK, Saggini A, Cerulli G, Caraffa A, Antinolfi P, Pantalone A, Frydas S, Rosati M, Tei M, Speziali A, et al: Neuropeptide NGF mediates neuro-immune response and inflammation through mast cell activation. J Biol Regul Homeost Agents. 28:177–181. 2014.PubMed/NCBI
26	Micera A, Stampachiacchiere B, Normando EM, Lambiase A and Bonini S and Bonini S: Nerve growth factor modulates toll-like receptor (TLR) 4 and 9 expression in cultured primary VKC conjunctival epithelial cells. Mol Vis. 15:2037–2044. 2009.PubMed/NCBI
27	Shyu KG, Liou JY, Wang BW, Fang WJ and Chang H: Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart. J Biomed Sci. 12:409–420. 2005. View Article : Google Scholar : PubMed/NCBI
28	Shyu KG, Lu MJ, Chang H, Sun HY, Wang BW and Kuan P: Carvedilol modulates the expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in a rat model of volume-overload heart failure. J Card Fail. 11:152–159. 2005. View Article : Google Scholar : PubMed/NCBI
29	Wang F, Xu P, Xie KC, Chen XF, Li CY and Huang Q: Effects of tumor microenviromental factors on VEGF expression. Biomed Rep. 1:539–544. 2013.PubMed/NCBI
30	Taurone S, Ripandelli G, Pacella E, Bianchi E, Plateroti AM, De Vito S, Plateroti P, Grippaudo FR, Cavallotti C and Artico M: Potential regulatory molecules in the human trabecular meshwork of patients with glaucoma: Immunohistochemical profile of a number of inflammatory cytokines. Mol Med Rep. 11:1384–1390. 2015.PubMed/NCBI
31	Goi T, Nakazawa T, Hirono Y and Yamaguchi A: The anti-tumor effect is enhanced by simultaneously targeting VEGF and PROK1 in colorectal cancer. Oncotarget. 8:6053–6061. 2015. View Article : Google Scholar
32	de Boer RA, Siebelink HJ, Tio RA, Boomsma F and van Veldhuisen DJ: Carvedilol increases plasma vascular endothelial growth factor (VEGF) in patients with chronic heart failure. Eur J Heart Fail. 3:331–333. 2001. View Article : Google Scholar : PubMed/NCBI